Panacea Life Sciences Holdings, Inc.
PLSH· OTC
Filed Nov 14, 2016 · 10-Q · 45 days after period end · 0001415889-16-007400
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $213.00 |
| Net Income | -$359.81K | -$112.63K | -$74.89K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end